Organization: Health Canada
Year: 2023
Month: May
Request Number: A-2022-001517
Request Summary: Adverse Drug Reactions (ADRs) for VEDOLIZUMAB. Report numbers: E2B_05980473, E2B_06029464. ADRs for ONDANSETRON. Report numbers: E2B_05986311, E2B_05988217, E2B_05974379, E2B_05970800. ADR for PANTOLOC. Report number: 001022041. ADRs for MEZAVANT. Report numbers: E2B_06024257, E2B_05992334. ADR for PANTOPRAZOLE SODIUM. Report number: 001021230.
Disposition: Disclosed in part
Number of pages: 186